2Yamada K, Fumsawa S, Saito K,et al. Co pcurrent use of granulocyte colony stimulating factor with low dose cytos, i6e arabinosde and find Aclambicin for previously treated acute myelogenous leukemia:a pilot study. Leukemia, 1995,9:1 014.
3Akashi K,Eto T,Shibuya T,et al. Aelarubicin induces differentiation of leukemia, progenitors in myelodysplastie syndrome cooperating with granulocyte colony stimulating factosvLeukemia Res,2000,24: 243-248,
5Heil G, Hoelzer D, Sanz MA, et al. A randomized, double-blind, placebo-controlled, phase Ⅲ study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood, 1997 ;90:4710 -4718
6De Witte T, Muus P, De Pauw B, et al. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer, 1990 ;66:831 - 837
8Jackson G,Taylor P, Smith GM, et al. A multicentre, open, noncmoparative phase Ⅱ study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. Br J Haematol, 2001 ; 112 : 127 - 137
9Becker PS, Growth factor priming in therapy of acute myelogenous leukemia. Curr Hematol Rep, 2004;3:413 -418
10Lowenberg B, van Putten W, Theobald M, et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia, N Engl J Med, 2003; 349:743 - 752
